Society for Clinical Research Sites (SCRS) and Fortrea Partner to Advance Collaboration in Clinical Research
Fortrea (Nasdaq: FTRE) has announced its sponsorship of the SCRS Collaborate Forward working group, joining 16 leading Global Impact Partner organizations. The initiative aims to reduce administrative burdens in clinical research and improve trial efficiency through enhanced collaboration.
The working group will focus initially on study startup, developing best practices and solutions that can be implemented across the clinical research ecosystem. The group's efforts will concentrate on improving internal processes to enhance site sustainability and trial efficiency, ultimately benefiting patient experience.
Progress updates will be shared throughout 2025 via SCRS Site Solutions Summits and publications. The partnership represents a significant step toward fostering industry-wide innovation and emphasizes Fortrea's commitment to placing research sites at the center of clinical trial planning.
Fortrea (Nasdaq: FTRE) ha annunciato il suo patrocinio al gruppo di lavoro SCRS Collaborate Forward, unendosi a 16 organizzazioni leader come Partner Global Impact. L'iniziativa mira a ridurre i carichi amministrativi nella ricerca clinica e a migliorare l'efficienza degli studi attraverso una collaborazione potenziata.
Il gruppo di lavoro si concentrerà inizialmente sull'avvio degli studi, sviluppando le migliori pratiche e soluzioni che possono essere implementate nell'ecosistema della ricerca clinica. Gli sforzi del gruppo si concentreranno sul miglioramento dei processi interni per aumentare la sostenibilità dei siti e l'efficienza degli studi, a beneficio finale dell'esperienza dei pazienti.
Gli aggiornamenti sui progressi saranno condivisi durante il 2025 attraverso i Summit delle Soluzioni per i Siti SCRS e le pubblicazioni. La partnership rappresenta un passo significativo verso la promozione dell'innovazione a livello di settore e sottolinea l'impegno di Fortrea nel mettere i siti di ricerca al centro della pianificazione degli studi clinici.
Fortrea (Nasdaq: FTRE) ha anunciado su patrocinio al grupo de trabajo SCRS Collaborate Forward, uniéndose a 16 organizaciones líderes como Socios Globales de Impacto. La iniciativa tiene como objetivo reducir las cargas administrativas en la investigación clínica y mejorar la eficiencia de los ensayos a través de una colaboración mejorada.
El grupo de trabajo se enfocará inicialmente en el inicio de estudios, desarrollando las mejores prácticas y soluciones que se pueden implementar en el ecosistema de investigación clínica. Los esfuerzos del grupo se concentrarán en mejorar los procesos internos para aumentar la sostenibilidad de los sitios y la eficiencia de los ensayos, beneficiando en última instancia la experiencia del paciente.
Las actualizaciones sobre el progreso se compartirán a lo largo de 2025 a través de las Cumbres de Soluciones de Sitios de SCRS y publicaciones. La asociación representa un paso significativo hacia la promoción de la innovación en toda la industria y enfatiza el compromiso de Fortrea de colocar los sitios de investigación en el centro de la planificación de ensayos clínicos.
Fortrea (Nasdaq: FTRE)는 16개의 주요 글로벌 임팩트 파트너 조직과 함께 SCRS Collaborate Forward 작업 그룹의 후원을 발표했습니다. 이 이니셔티브는 임상 연구의 행정적 부담을 줄이고 향상된 협업을 통해 시험의 효율성을 개선하는 것을 목표로 합니다.
작업 그룹은 처음에 연구 시작에 집중하며, 임상 연구 생태계 전반에 걸쳐 구현할 수 있는 모범 사례 및 솔루션을 개발할 것입니다. 그룹의 노력은 내부 프로세스를 개선하여 사이트의 지속 가능성과 시험의 효율성을 높이는 데 집중하며, 궁극적으로 환자의 경험에 혜택을 줄 것입니다.
진행 상황 업데이트는 2025년 동안 SCRS 사이트 솔루션 서밋 및 출판물을 통해 공유될 것입니다. 이 파트너십은 산업 전반의 혁신을 촉진하는 중요한 단계이며, Fortrea가 임상 시험 계획의 중심에 연구 사이트를 두려는 의지를 강조합니다.
Fortrea (Nasdaq: FTRE) a annoncé son parrainage du groupe de travail SCRS Collaborate Forward, rejoignant 16 organisations partenaires d'impact global. L'initiative vise à réduire les charges administratives dans la recherche clinique et à améliorer l'efficacité des essais grâce à une collaboration renforcée.
Le groupe de travail se concentrera initialement sur le démarrage des études, en développant des pratiques exemplaires et des solutions qui peuvent être mises en œuvre dans l'ensemble de l'écosystème de recherche clinique. Les efforts du groupe se concentreront sur l'amélioration des processus internes afin d'accroître la durabilité des sites et l'efficacité des essais, au bénéfice final de l'expérience des patients.
Des mises à jour sur les progrès seront partagées tout au long de 2025 via les Sommets des Solutions de Sites SCRS et des publications. Le partenariat représente un pas significatif vers la promotion de l'innovation à l'échelle de l'industrie et souligne l'engagement de Fortrea à placer les sites de recherche au centre de la planification des essais cliniques.
Fortrea (Nasdaq: FTRE) hat seine Sponsoring des SCRS Collaborate Forward Arbeitskreises angekündigt und sich 16 führenden Global Impact Partner Organisationen angeschlossen. Die Initiative zielt darauf ab, administrative Belastungen in der klinischen Forschung zu reduzieren und die Effizienz von Studien durch verbesserte Zusammenarbeit zu steigern.
Der Arbeitskreis wird sich zunächst auf den Studienstart konzentrieren und bewährte Praktiken sowie Lösungen entwickeln, die im gesamten klinischen Forschungsökosystem umgesetzt werden können. Die Bemühungen der Gruppe werden sich darauf konzentrieren, interne Prozesse zu verbessern, um die Nachhaltigkeit der Standorte und die Effizienz der Studien zu erhöhen, was letztendlich der Patientenerfahrung zugutekommt.
Fortschrittsaktualisierungen werden im Laufe des Jahres 2025 über die SCRS Site Solutions Summits und Veröffentlichungen geteilt. Die Partnerschaft stellt einen bedeutenden Schritt zur Förderung von Innovationen in der gesamten Branche dar und betont Fortreas Engagement, Forschungsstandorte in den Mittelpunkt der Planung klinischer Studien zu stellen.
- Strategic partnership with SCRS enhances Fortrea's position in clinical trial optimization
- Collaboration with 16 leading Global Impact Partners expands industry influence
- Initiative focuses on reducing operational costs through administrative burden reduction
- None.
Fortrea to Sponsor SCRS’ Collaborate Forward Working Group, Encouraging Collaboration for More Efficient Clinical Trials
DURHAM, N.C., Feb. 20, 2025 (GLOBE NEWSWIRE) -- The Society for Clinical Research Sites (SCRS) and Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), are pleased to announce Fortrea’s sponsorship of the SCRS Collaborate Forward working group.
Comprising 16 leading Global Impact Partner organizations, the Collaborate Forward working group will explore and develop best practices to reduce administrative burdens across the clinical research ecosystem. The group is committed to fostering transparency and collaboration to tackle challenges faced by clinical research sites. By improving internal processes, it aims to make sites more sustainable and trials more efficient—ultimately leading to a smoother experience for patients.
Fortrea’s sponsorship marks a significant investment in fostering industry-wide innovation and reflects the company’s dedication to placing sites at the forefront of clinical trial planning.
“We are excited to partner with SCRS to launch and support this working group,” said Mike Clay, senior vice president of Global Project Delivery at Fortrea. “Clinical trials are becoming increasingly complex, and the industry faces mounting pressure to accelerate innovation for patients. We believe that collaboration with clinical research sites is key to unlocking efficiencies and productivity gains that will streamline the clinical trial process. This initiative will develop tangible solutions that clinical study sponsors, CROs, vendors, sites and patient advocacy groups can rally behind. As a leading CRO, we are proud to be at the forefront of this effort, ensuring that sites remain central to driving progress and fostering greater industry-wide collaboration to bring life-changing treatments to patients faster.”
“Clinical research requires a unique interdependency to generate the best outcomes. Collaborate Forward will share partnership successes that impact the people, process and technology improving clinical research today,” added Sean Soth, senior vice president, Strategy and Global Business Partnerships, SCRS. “We are pleased to welcome Fortrea as the charter sponsor of Collaborate Forward. This partnership underscores the value of cross-industry collaboration and the collective effort needed to drive meaningful progress in creating a more connected and efficient clinical trial ecosystem.”
Collaborate Forward will initially focus on study startup, showcasing the advantages of collaboration through compelling stories, case studies and data-driven insights. The group will convene regularly to exchange insights, assess industry trends and develop pragmatic tools that sponsors and CROs can implement within their organizations. Updates on the working group's progress will be shared throughout 2025 via SCRS Site Solutions Summits and publications, highlighting key findings and collaborative achievements.
SCRS invites sponsors and CROs committed to site sustainability to join this effort and contribute to shaping a more effective and synergistic clinical research landscape. For more information on how to participate, please contact Brian Egan.
About The Society for Clinical Research Sites
The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 11,000 research sites globally, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs.org. Our voice. Our community. Your success.
About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter).
SCRS Contacts:
Marissa Hill (Media) – 267-865-3296, marissa.hill@myscrs.org
Brian Egan (Media) – 518-207-6965, brianeegan@gmail.com
Fortrea Contacts:
Galen Wilson (Media) – 703-298-0802, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com
FAQ
What is the purpose of Fortrea's partnership with SCRS Collaborate Forward working group?
How will FTRE's Collaborate Forward initiative impact clinical trial processes in 2025?
What are the main objectives of Fortrea's SCRS partnership for clinical research sites?
How will Fortrea (FTRE) measure success in the Collaborate Forward working group?
